Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
about
Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverHepatocellular carcinoma: A comprehensive reviewLiver transplantation: fifty years of experience.Model for end-stage liver disease score and MELD exceptions: 15 years later.A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model".Long-term outcome in liver transplantation candidates with portopulmonary hypertension.Liver-allocation policies for patients affected by HCC in Europe.Subjective parameters markedly limit the referral of transplantation candidates to liver transplant centres.Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis.Meeting report of the 19th Annual International Congress of the International Liver Transplantation Society (Sydney Convention and Exhibition Centre, Sydney, Australia, June 12-15, 2013).A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network.Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: a strategy improving survival.A Donor Quality Index for liver transplantation: development, internal and external validation.
P2860
Q26766699-377F4822-91D3-4F2C-94E7-BCCC4ABA61B8Q28087638-A4F60C06-DE5C-4AEC-B976-B141F2F7985BQ33594885-F1E4BEA9-F10B-491E-9BE8-FF535C5910E1Q38504284-4B1D48E1-9733-490F-9735-429BC1A70DFBQ38566746-6BC1C2E8-1781-4C21-810F-E04D6FAFC22FQ39082532-4EFDF2E2-6D64-469F-9003-DEEF34198A7AQ39284986-2B4179A0-9433-4FE0-85A3-1793990AAB4CQ41098829-1C552A13-8009-444C-972D-07894D6C4C17Q41578261-030B356C-3726-47B2-90D7-67E6357070EDQ42705264-0C84F622-6E2F-459F-802E-1AD581592E24Q46493912-DAD5CA8C-CF88-46A4-A0BD-5D69246DDE70Q46894207-44D2DEAA-5566-4571-9B1D-5BBBDEDF0F62Q51823221-8F76874F-E7A0-40D6-932C-D86CB929729EQ55516054-B334BB4D-4C99-42C1-8FD2-ACBE10E8130E
P2860
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Model for end-stage liver dise ...... based liver allocation system.
@en
Model for end-stage liver dise ...... based liver allocation system.
@nl
type
label
Model for end-stage liver dise ...... based liver allocation system.
@en
Model for end-stage liver dise ...... based liver allocation system.
@nl
prefLabel
Model for end-stage liver dise ...... based liver allocation system.
@en
Model for end-stage liver dise ...... based liver allocation system.
@nl
P2093
P2860
P50
P356
P1476
Model for end-stage liver dise ...... based liver allocation system.
@en
P2093
Ameet Mandot
Christophe Duvoux
Denis Castaing
Dominique Thabut
François Durand
Georges Pageaux
Jacques Belghiti
Olivier Chazouillères
Yves-Patrice Le Treut
P2860
P304
P356
10.1002/LT.22363
P50
P577
2011-10-01T00:00:00Z